Novo Nordisk A/S (NOVO-B): Eigentümerstruktur
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 276,45 Dänische Krone | 391,3 Dänische Krone | 214,048 Dänische Krone |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 310,167 Dänische Krone | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 3.344.053.124 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Novo Nordisk A/S
Mitarbeiter 66.700
Handelsplatz CO
Ticker Symbol NOVO-B
IPO Datum -
Adresse Novo Alle 1, Bagsvaerd, Denmark, 2880
Webseite https://www.novonordisk.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Karsten Munk Knudsen | Executive VP, CFO & Member of the Management Board |
| 2 | Mr. Maziar Mike Doustdar B.A. | President, CEO & Member of the Management Board |
| 3 | Dr. Martin Holst Lange | EVP of R&D, Chief Scientific Officer and Member of the Management Board |
| 4 | Ms. Tania Sabroe | EVP of People, Organisation and Corporate Affairs & Member of Management Board |
| 5 | Ms. Thilde Hummel Bogebjerg | Executive VP of Enterprise IT & Quality and Member of Management Board |
| 6 | Mr. John F. Kuckelman | SVP, Group General Counsel, Global Legal, IP & Security and Member of Management Board |
| 7 | Mr. Emil Kongshoej Larsen | EVP of International Operations & Member of Management Board |
| 8 | Ms. Elin Jager | SVP, Chief of Staff to CEO, Corporate Strategy & Sustainability and Member of Management Board |
| 9 | Mr. Jamey Millar | Executive VP of US Operations & Member of Management Board |
| 10 | Ms. Hong Chow | Executive VP of Product & Portfolio Strategy and Member of Management Board |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.